Not Tagged
pfizer
['breast', 'pfizer']
the part c design of a phase 1/2 study evaluating safety &amp; clinical activity of a er protac protein degrader + a cdk4/6i in pts w/ advanced er+/her2- #breastcancer who previously received endocrine therapy is being presented at #asco22 tps1120 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ